What causes pk

What is Phenylketonuria (PKU)?

Phenylketonuria, commonly known as PKU, is a rare genetic disorder that affects how the body processes a specific building block of protein called an amino acid. Amino acids are essential for building proteins, and phenylalanine is one of the most common ones found in our diet. In individuals with PKU, the body lacks or has a deficiency in an enzyme called phenylalanine hydroxylase (PAH). This enzyme is crucial for converting phenylalanine into another amino acid, tyrosine, which the body needs for various functions.

When the PAH enzyme is not working correctly, phenylalanine cannot be converted efficiently. As a result, phenylalanine builds up to high and toxic levels in the bloodstream. This accumulation is particularly damaging to the brain and central nervous system, especially during early development. If left untreated, this buildup can lead to severe intellectual disability, developmental delays, behavioral problems, and other serious health issues.

What Causes PKU?

The root cause of PKU lies in genetic mutations. Specifically, PKU is caused by mutations in the PAH gene. This gene provides instructions for making the enzyme phenylalanine hydroxylase. The PAH enzyme is located primarily in the liver and its main job is to break down phenylalanine, converting it into tyrosine. Tyrosine is then used to create neurotransmitters (chemical messengers in the brain) and melanin (a pigment in skin and hair).

When mutations occur in the PAH gene, the enzyme produced may be partially or completely non-functional. This genetic defect is inherited in an autosomal recessive pattern. This means that for a person to have PKU, they must inherit two copies of the mutated PAH gene – one from each parent. If a person inherits only one copy of the mutated gene and one working copy, they become a carrier of PKU but typically do not show symptoms themselves. However, they can pass the mutated gene on to their children.

How is PKU Diagnosed?

Fortunately, PKU is one of the conditions included in newborn screening programs in many countries around the world. This screening is typically performed a day or two after birth, usually by collecting a few drops of blood from the baby's heel. The blood sample is then tested for the presence of high levels of phenylalanine or for indicators of the faulty PAH enzyme.

Early diagnosis through newborn screening is critical because it allows for immediate intervention. Without screening, PKU might not be detected until a baby starts showing symptoms, which could be as late as several months after birth. By the time symptoms appear, irreversible neurological damage may have already occurred. Therefore, newborn screening is a vital public health measure that has significantly improved the long-term outlook for individuals with PKU.

What are the Symptoms of Untreated PKU?

The symptoms of PKU can vary in severity depending on the degree of enzyme deficiency and how early treatment begins. In infants with untreated PKU, symptoms may not be apparent at birth but typically emerge within the first few months of life. These can include:

• A musty or mouse-like odor in the baby's breath, skin, or urine, due to the buildup of phenylalanine byproducts.
• Skin rashes (eczema).
• Neurological problems, such as seizures.
• Developmental delays, including slow learning and failure to meet developmental milestones.
• Microcephaly (a smaller than normal head size).
• Behavioral issues, such as hyperactivity, irritability, and aggression, especially in older children.
• Intellectual disability, which can range from mild to severe if left untreated.

It's important to note that with early diagnosis and consistent treatment, individuals with PKU can lead healthy lives with normal or near-normal intelligence and fewer health complications.

How is PKU Treated?

The primary and most effective treatment for PKU is a lifelong, special diet that is very low in phenylalanine. Since phenylalanine is found in protein-rich foods, this diet restricts the intake of meat, fish, poultry, eggs, dairy products, nuts, and legumes. Instead, individuals with PKU consume specially formulated medical foods and drinks that provide necessary protein without the high levels of phenylalanine. They also consume small, carefully measured amounts of fruits, vegetables, and certain grains to ensure they receive adequate nutrition.

The goal of the diet is to keep blood phenylalanine levels within a safe range, typically between 2 to 6 mg/dL for infants and 4 to 8 mg/dL for children and adults, although specific targets can vary. Regular blood tests are essential to monitor these levels. In addition to dietary management, some individuals may benefit from medications, such as sapropterin dihydrochloride (Kuvan), which can help improve the function of the remaining PAH enzyme activity.

What is the Long-Term Outlook for People with PKU?

The long-term outlook for individuals diagnosed with PKU through newborn screening and treated with a strict low-phenylalanine diet is generally very positive. With consistent adherence to the special diet and regular medical monitoring, most individuals can achieve normal or near-normal cognitive development and lead fulfilling lives. They can attend school, pursue careers, and have families.

However, challenges can arise. Maintaining the strict diet can be difficult, especially during adolescence and adulthood when social pressures and independence can make adherence more challenging. For women with PKU who are planning to become pregnant, it is crucial to follow the diet very strictly before and during pregnancy. This is known as maternal PKU, and high phenylalanine levels in the mother can cause severe birth defects and developmental problems in the fetus, even if the baby does not have PKU.